RDY
Dr. Reddy's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +12.5% ·
share flow +30.0% ·
net new positions +11.1%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 8.76M | $110.06M | n/a | −1 |
| Q2 2026 | 83 | +2 | 105.67M | $1.53B | +6 | −4 |
| Q1 2026 | 82 | +2 | 99.82M | $1.38B | +9 | −7 |
| Q4 2025 | 79 | +1 | 89.69M | $1.26B | +1 | n/a |
| Q3 2025 | 15 | +1 | 51.12M | $714.60M | +1 | n/a |
| Q2 2025 | 11 | -3 | 34.60M | $520.04M | n/a | −3 |
| Q1 2025 | 11 | +2 | 23.21M | $306.17M | +2 | n/a |
| Q4 2024 | 9 | +1 | 22.23M | $350.98M | +1 | n/a |
| Q3 2024 | 7 | -2 | 2.98M | $236.56M | +1 | −3 |
| Q2 2024 | 9 | n/a | 3.04M | $231.32M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 9.42M | +382.9% | $148.72M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 4.66M | n/a | $73.52M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 2.84M | +1676.4% | $44.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Fisher Asset Management ✦ | 2.47M | +402.5% | $38.98M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.18M | +8779.0% | $18.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 896.16K | +431.9% | $14.15M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 429.89K | +256.3% | $6.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 331.21K | +350.0% | $5.23M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 13.46K | New | $212,596 | 0.0% | New | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $212,596 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 245 holders, 116.00M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.